You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Cooles F, Anderson A, Drayton T, et al
SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies
Annals of the Rheumatic Diseases 2016;75:725-726.